Company intelligence / Profile preview

Gansu Xinlan Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Gansu Xinlan Pharmaceutical is a China-based pharmaceutical company primarily engaged in the research, development, production, and sale of chemical drugs and Traditional Chinese Medicine (TCM). The company operates a large-scale manufacturing base in the Gansu province, focusing on essential medicines including antibiotics, cardiovascular treatments, and respiratory drugs. Its product portfolio encompasses various dosage forms such as tablets, capsules, and granules. Gansu Xinlan Pharmaceutical serves both domestic and regional markets, positioning itself as a key integrated supplier of generic pharmaceuticals and health products in Northwest China.

Therapeutic areas: GastroenterologyCardiovascularPulmonologyInfectious Diseases
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Gansu Xinlan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gansu Xinlan Pharmaceutical.